HK1008328A1 - Endothelin antagonists - Google Patents

Endothelin antagonists

Info

Publication number: HK1008328A1
Authority: HK; Hong Kong
Prior art keywords: endothelin antagonists; processes; preparing; endothelin; antagonists
Prior art date: 1994-08-19

Application number

HK98109192A

Other languages

English (en)

Inventor

Martin Winn

Steven A Boyd

Charles W Hutchin

Hwan-Soo Jae

Andrew S Tasker

Thomas W Vongeldern

Jeffrey A Kester

Bryan K Sorensen

Original Assignee

Abbott Lab

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1994-08-19

Filing date

1998-07-15

Publication date

1999-05-07

1995-05-30 Priority claimed from US08/442,575 external-priority patent/US5767144A/en

1998-07-15 Application filed by Abbott Lab filed Critical Abbott Lab

1999-05-07 Publication of HK1008328A1 publication Critical patent/HK1008328A1/xx

Links

102000002045 Endothelin Human genes 0.000 title abstract 2
108050009340 Endothelin Proteins 0.000 title abstract 2
239000005557 antagonist Substances 0.000 title abstract 2
ZUBDGKVDJUIMQQ-UBFCDGJISA-N endothelin-1 Chemical compound C([C@@H](C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(O)=O)NC(=O)[C@H]1NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@@H](CC=2C=CC(O)=CC=2)NC(=O)[C@H](C(C)C)NC(=O)[C@H]2CSSC[C@@H](C(N[C@H](CO)C(=O)N[C@@H](CO)C(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@H](CC(O)=O)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCC(O)=O)C(=O)N2)=O)NC(=O)[C@@H](CO)NC(=O)[C@H](N)CSSC1)C1=CNC=N1 ZUBDGKVDJUIMQQ-UBFCDGJISA-N 0.000 title abstract 2
239000000543 intermediate Substances 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/12—Antihypertensives
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D207/00—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D207/02—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D207/04—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members
- C07D207/10—Heterocyclic compounds containing five-membered rings not condensed with other rings, with one nitrogen atom as the only ring hetero atom with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D207/16—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/572—Five-membered rings
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
- C07F9/02—Phosphorus compounds
- C07F9/547—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom
- C07F9/553—Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having one nitrogen atom as the only ring hetero atom
- C07F9/576—Six-membered rings
- C07F9/59—Hydrogenated pyridine rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
General Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Animal Behavior & Ethology (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Cardiology (AREA)
Heart & Thoracic Surgery (AREA)
Molecular Biology (AREA)
Biochemistry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pain & Pain Management (AREA)
Rheumatology (AREA)
Hospice & Palliative Care (AREA)
Epidemiology (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Steroid Compounds (AREA)

HK98109192A 1994-08-19 1998-07-15 Endothelin antagonists HK1008328A1 (en)

Applications Claiming Priority (5)

Application Number	Priority Date	Filing Date	Title
US29334994A	1994-08-19	1994-08-19
US33471794A	1994-11-04	1994-11-04
US08/442,575 US5767144A (en)	1994-08-19	1995-05-30	Endothelin antagonists
US49799895A	1995-08-02	1995-08-02
PCT/US1995/009924 WO1996006095A1 (fr)	1994-08-19	1995-08-04	Antagonistes d'endotheline

Publications (1)

Publication Number	Publication Date
HK1008328A1 true HK1008328A1 (en)	1999-05-07

Family

ID=27501591

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
HK98109192A HK1008328A1 (en)	1994-08-19	1998-07-15	Endothelin antagonists

Country Status (13)

Country	Link
EP (2)	EP0776324B1 (fr)
JP (1)	JP3741441B2 (fr)
KR (2)	KR100447000B1 (fr)
AT (1)	ATE219077T1 (fr)
AU (1)	AU711832B2 (fr)
CA (2)	CA2195677C (fr)
DE (1)	DE69527072T2 (fr)
DK (1)	DK0776324T3 (fr)
ES (1)	ES2179881T3 (fr)
HK (1)	HK1008328A1 (fr)
IL (2)	IL114894A (fr)
PT (1)	PT776324E (fr)
WO (1)	WO1996006095A1 (fr)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5852046A (en) *	1993-08-03	1998-12-22	Hoechst Aktiengesellschaft	Benzo-fused heterocyclic compounds having a 5-membered ring processes for their preparation their use as medicaments their use as diagnostic agents and medicaments containing them
US7208517B1 (en)	1994-08-19	2007-04-24	Abbott Labortories	Endothelin antagonists
US5767144A (en) *	1994-08-19	1998-06-16	Abbott Laboratories	Endothelin antagonists
US6162927A (en) *	1994-08-19	2000-12-19	Abbott Laboratories	Endothelin antagonists
HUP9902316A3 (en) *	1996-02-13	2001-12-28	Abbott Lab	4-(benzo-1,3-dioxolyl)-pyrrolidine-3-carboxylic acid derivatives as endothelin antagonists and pharmaceutical compositions containing them
AU781355B2 (en) *	1996-02-13	2005-05-19	Abbott Laboratories	Novel benzo-1,3-dioxolyl-and benzofuranyl substituted pyrrolidine derivatives as endothelin antagonists
CA2245587C (fr) *	1996-02-13	2008-12-30	Abbott Laboratories	Derives de pyrrolidine a substitution benzo-1,3-dioxolyl et benzofuranyl servant d'antagonistes de l'endotheline
AU2763602A (en) *	1996-02-13	2002-05-16	Abbott Laboratories	Endothelin antagonists
US5801250A (en) *	1996-12-13	1998-09-01	Abbott Laboratories	Process for the stereoselective production of nitro-enamine compounds
US6030975A (en) *	1997-03-14	2000-02-29	Basf Aktiengesellschaft	Carboxylic acid derivatives, their preparation and use in treating cancer
WO1998057933A1 (fr) *	1997-06-17	1998-12-23	Abbott Laboratories	Derives d'acide carboxylique de pyrrolidine comme antagonistes d'endotheline
TR200101233T2 (tr) *	1997-08-04	2002-06-21	Abbott Laboratories	Endotelin antagonistleri.
IL125658A0 (en)	1997-08-18	1999-04-11	Hoffmann La Roche	Ccr-3 receptor antagonists
US6339087B1 (en)	1997-08-18	2002-01-15	Syntex (U.S.A.) Llc	Cyclic amine derivatives-CCR-3 receptor antagonists
DE19743681A1 (de) *	1997-10-02	1999-04-08	Knoll Ag	Methode zur Verhinderung der Transplantatabstoßung
US6410554B1 (en)	1998-03-23	2002-06-25	Merck & Co., Inc.	Combination therapy for the treatment of benign prostatic hyperplasia
JP2002524551A (ja) *	1998-09-14	2002-08-06	ワーナー−ランバート・カンパニー	分枝鎖アルキルピロリジン−３−カルボン酸
BR9915735A (pt)	1998-11-20	2001-09-04	Hoffmann La Roche	Antagonistas receptores de ccr-3 de piperidina
WO2002017912A1 (fr) *	2000-08-31	2002-03-07	Abbott Laboratories	Antagonistes de l'endotheline
US8168616B1 (en)	2000-11-17	2012-05-01	Novartis Ag	Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
GB0327839D0 (en)	2003-12-01	2003-12-31	Novartis Ag	Organic compounds
JP2007529459A (ja)	2004-03-17	2007-10-25	ノバルティスアクチエンゲゼルシャフト	治療に置けるレニン阻害剤の使用
WO2009026517A2 (fr)	2007-08-22	2009-02-26	Gilead Colorado, Inc.	Thérapie pour complications du diabète
WO2011114103A1 (fr)	2010-03-18	2011-09-22	Biolipox Ab	Pyrimidinones pour usage médicamenteux
JO2998B1 (ar)	2010-06-04	2016-09-05	Amgen Inc	مشتقات بيبيريدينون كمثبطات mdm2 لعلاج السرطان
EP2760845B1 (fr)	2011-09-27	2016-11-16	Amgen Inc.	Heterocycles utilises comme inhibiteurs de mdm2 dans le traitement du cancer
US11407721B2 (en)	2013-02-19	2022-08-09	Amgen Inc.	CIS-morpholinone and other compounds as MDM2 inhibitors for the treatment of cancer
MX368703B (es)	2013-02-28	2019-10-11	Amgen Inc	Un inhibidor de mdm2 derivado de acido benzoico para el tratamiento del cancer.
US9758495B2 (en)	2013-03-14	2017-09-12	Amgen Inc.	Heteroaryl acid morpholinone compounds as MDM2 inhibitors for the treatment of cancer
JOP20200296A1 (ar)	2013-06-10	2017-06-16	Amgen Inc	عمليات صنع وأشكال بلورية من mdm2 مثبط
US8962675B1 (en) *	2013-09-12	2015-02-24	Abbvie Inc.	Atrasentan mandelate salts
KR102091932B1 (ko)	2018-08-16	2020-03-20	장남순	안전하고 간편한 접첩구조를 갖는 접이식 트램펄린

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3342833A (en) *	1964-08-07	1967-09-19	Shell Oil Co	Pyrrolidine production from aziridines and olefins
RU2125980C1 (ru) *	1991-11-05	1999-02-10	Смитклайн Бичам Корпорейшн	Антагонисты эндотелиновых рецепторов, фармкомпозиция, способ их получения, способ подавления эндотелиновых рецепторов
WO1994002474A1 (fr) *	1992-07-17	1994-02-03	Smithkline Beecham Corporation	Antagonistes du recepteur de l'endotheline

1995
- 1995-08-04 AT AT95928323T patent/ATE219077T1/de active
- 1995-08-04 JP JP50810196A patent/JP3741441B2/ja not_active Expired - Lifetime
- 1995-08-04 PT PT95928323T patent/PT776324E/pt unknown
- 1995-08-04 EP EP95928323A patent/EP0776324B1/fr not_active Expired - Lifetime
- 1995-08-04 KR KR1019970701079A patent/KR100447000B1/ko not_active IP Right Cessation
- 1995-08-04 CA CA002195677A patent/CA2195677C/fr not_active Expired - Lifetime
- 1995-08-04 DK DK95928323T patent/DK0776324T3/da active
- 1995-08-04 CA CA002517691A patent/CA2517691A1/fr not_active Abandoned
- 1995-08-04 EP EP01125462A patent/EP1186603A3/fr not_active Withdrawn
- 1995-08-04 WO PCT/US1995/009924 patent/WO1996006095A1/fr active Search and Examination
- 1995-08-04 AU AU32137/95A patent/AU711832B2/en not_active Expired
- 1995-08-04 KR KR10-2004-7004682A patent/KR100483222B1/ko not_active IP Right Cessation
- 1995-08-04 ES ES95928323T patent/ES2179881T3/es not_active Expired - Lifetime
- 1995-08-04 DE DE69527072T patent/DE69527072T2/de not_active Expired - Lifetime
- 1995-08-10 IL IL11489495A patent/IL114894A/xx not_active IP Right Cessation
- 1995-08-10 IL IL134905A patent/IL134905A/en not_active IP Right Cessation
1998
- 1998-07-15 HK HK98109192A patent/HK1008328A1/xx not_active IP Right Cessation

Also Published As

Publication number	Publication date
ATE219077T1 (de)	2002-06-15
KR100447000B1 (ko)	2004-12-10
AU3213795A (en)	1996-03-14
KR100483222B1 (ko)	2005-04-15
IL134905A0 (en)	2001-05-20
DE69527072T2 (de)	2003-02-13
IL114894A (en)	2003-04-10
CA2195677C (fr)	2005-11-08
WO1996006095A1 (fr)	1996-02-29
KR970705561A (ko)	1997-10-09
DE69527072D1 (de)	2002-07-18
PT776324E (pt)	2002-11-29
IL114894A0 (en)	1995-12-08
IL134905A (en)	2009-06-15
JPH10504565A (ja)	1998-05-06
EP1186603A2 (fr)	2002-03-13
EP1186603A3 (fr)	2003-07-09
CA2195677A1 (fr)	1996-02-29
DK0776324T3 (da)	2002-10-07
EP0776324A1 (fr)	1997-06-04
ES2179881T3 (es)	2003-02-01
JP3741441B2 (ja)	2006-02-01
EP0776324B1 (fr)	2002-06-12
KR20040045036A (ko)	2004-05-31
AU711832B2 (en)	1999-10-21
CA2517691A1 (fr)	1996-02-29

Legal Events

Date	Code	Title	Description
2004-12-15	PF	Patent in force
2015-08-21	PE	Patent expired	Effective date: 20150803

Publication	Publication Date	Title
HK1008328A1 (en)	1999-05-07	Endothelin antagonists
GR3035526T3 (en)	2001-06-29	Retroviral protease inhibitors.
TW215434B (fr)	1993-11-01
PL292101A1 (en)	1992-08-10	Method of obtaining novel derivatives of cyclopentylpurine and cyclopentylpyrimidine
MX9603050A (es)	1997-03-29	Derivados de la 1-h-3-aril-pirrolidin-2,4-diona como agentes pesticidas.
GR3024255T3 (en)	1997-10-31	Benzo-fused lactams
AU667920B2 (en)	1996-04-18	New piperidine derivatives of benzimidazole
CA2245587A1 (fr)	1997-08-21	Derives de pyrrolidine a substitution benzo-1,3-dioxolyl et benzofuranyl servant d'antagonistes de l'endotheline
GB9718903D0 (en)	1997-11-12	Method,compositions and kits for increasing the oral bioavailability of pharmaceutical agents
MX9800483A (es)	1998-04-30	Derivados de piperazina y su uso como antagonistas de 5-ht1a.
AU627631B2 (en)	1992-08-27	Pyrimidone derivatives and analogs in the treatment of asthma or certain skin disorders
ES2104509A1 (es)	1997-10-01	Nuevos compuestos derivados de 2-(3,4-disustituido-1-piperazinil)-5-fluoropirimidina.
ZA9419B (en)	1995-01-04	Preparation process for sulphurated derivatives of imidazole and the new intermediates obtained.
PT855398E (pt)	2003-07-31	Derivados sasquiterpeno tendo actividade antiviral
EP0574271A3 (fr)	1994-04-06
IL103202A0 (en)	1993-02-21	Method for treating hypertension
TW275629B (fr)	1996-05-11
MX9701220A (es)	1998-02-28	Antagonistas de endotelina.
HU9202849D0 (en)	1992-11-30	Method for producing n,n',n-trisubstituted- 5-bis-amino-methylene-1,3-dioxane-4,6-dione derivatives and pharmaceutical preparatives containing them
DE68911394T2 (de)	1994-06-09	2-Amino-7-hydroxytetralin-ether.
ATE178071T1 (de)	1999-04-15	Endothelin-antagonisierendes peptid